70 employees
Scientific Excellence for IVD. With over 30 years of experience Hytest offers antibodies and antigens for improved patient outcomes in such areas as cardiac markers, infectious, neuroscience and autoimmune disease reagents.
1994
Hytest raised undisclosed on October 7, 2018
Investors: EQT
